Rhythm Pharmaceuticals Inc
(STU:1RV)
€
39.255
-0.74 (-1.85%)
Market Cap: 2.43 Bil
Enterprise Value: 2.24 Bil
PE Ratio: 0
PB Ratio: 42.35
GF Score: 52/100 - Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€40.05 (-0.76%)Earnings
- Q4 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2024€44.6Earnings
- Rhythm Pharmaceuticals Inc To Discuss On MC4R Pathway Programs Call TranscriptDec 06, 2023
- Q3 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2023€24 (-3.23%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Data Presentations Call TranscriptOct 18, 2023
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Rhythm Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Q2 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2023€15.9Earnings
- Rhythm Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Rhythm Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2023€17.9 (+1.13%)Earnings
- Rhythm Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2023€22.4Earnings
- Rhythm Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Q3 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022€22.4 (-1.75%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Hypothalamic Obesity Call TranscriptNov 02, 2022
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2022€11.8 (-0.84%)Earnings
- Rhythm Pharmaceuticals Inc To Discuss Hypothalamic Obesity Call TranscriptJul 12, 2022
- Rhythm Pharmaceuticals Inc To Discuss The FDA Approval Of IMCIVREE Call TranscriptJun 16, 2022
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Rhythm Pharmaceuticals Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2022€5.65 (+0.89%)Earnings
- Q4 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022€6.65 (+1.53%)Earnings
- Rhythm Pharmaceuticals Inc To Host Virtual Bardet-Biedl Syndrome (BBS) Event Call TranscriptFeb 16, 2022
- Q3 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2021€10.1 (-0.98%)Earnings
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Rhythm Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021€13.8 (-4.83%)Earnings
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 09, 2021
- Rhythm Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Rhythm Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptJan 26, 2021
- Rhythm Pharmaceuticals Inc Bardet-Biedl and Alstrom Syndromes Phase 3 Data Corporate Call TranscriptDec 22, 2020
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptNov 27, 2020
- Rhythm Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Rhythm Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 17, 2020
- Rhythm Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptSep 25, 2019
- Rhythm Pharmaceuticals Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptAug 07, 2019
- Rhythm Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Rhythm Pharmaceuticals, Inc. - Special Call TranscriptMar 28, 2019
Rhythm Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript
May 12, 2022 / 12:20AM GMT
Release Date Price:
€3.44
(+7.50%)
Daniel Giraldo Perez
BofA Securities, Research Division - Associate
Thank you for joining us on the last session of day 2 of the Bank of America Healthcare Conference. My name is Daniel Giraldo. I'm one of the associates in the smidcap biotech team at BofA. And joining me today is David Meeker, CEO of RHythm Pharmaceuticals. Welcome David. Thank you for joining us today.
David P. Meeker
Rhythm Pharmaceuticals, Inc. - Chairman, President & CEO
Thank you, Daniel.
Questions & Answers
Daniel Giraldo Perez
BofA Securities, Research Division - Associate
So maybe we can start by you giving us a brief overview of the company and maybe highlight key catalysts coming up in the next 12 months?
David P. Meeker
Rhythm Pharmaceuticals, Inc. - Chairman, President & CEO
Yes. Sure. So Rhythm is a relatively small biotechnology company focused on rare genetic diseases of obesity. The -- we work on a pathway in the brain called the melanocortin-4 pathway, which
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)